Imperva (IMPV) Earning Favorable Press Coverage, Report Finds

News articles about Imperva (NASDAQ:IMPV) have trended positive on Friday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imperva earned a news sentiment score of 0.31 on Accern’s scale. Accern also gave press coverage about the software maker an impact score of 45.0751365139949 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

A number of research firms have recently weighed in on IMPV. BidaskClub cut Imperva from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Monness Crespi & Hardt boosted their price target on Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Evercore ISI set a $56.00 price target on Imperva and gave the stock a “buy” rating in a report on Friday, July 28th. Imperial Capital cut their price target on Imperva from $57.00 to $50.00 and set an “outperform” rating for the company in a report on Tuesday, October 10th. Finally, William Blair cut Imperva from an “outperform” rating to a “market perform” rating in a report on Tuesday, October 10th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $52.38.

Imperva (NASDAQ:IMPV) traded up $0.35 during mid-day trading on Friday, reaching $40.80. The company’s stock had a trading volume of 156,500 shares, compared to its average volume of 444,064. Imperva has a 1 year low of $35.45 and a 1 year high of $52.40.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The firm had revenue of $83.89 million during the quarter, compared to the consensus estimate of $83.79 million. During the same quarter in the previous year, the business earned $0.08 earnings per share. The firm’s quarterly revenue was up 22.6% compared to the same quarter last year. equities research analysts forecast that Imperva will post -0.52 EPS for the current year.

In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the completion of the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.90% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: “Imperva (IMPV) Earning Favorable Press Coverage, Report Finds” was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with's FREE daily email newsletter.

Leave a Reply